While all acute bleeding episodes are considered serious and emergent, there are five major sites of serious bleeding in hemophilia that threaten life, limb, or function. They are intracranial or spinal cord bleeds, throat bleeds, intra-abdominal bleeds, limb compartment syndromes (e.g. thigh, calf, forearm, upper arm) and ocular bleeds. All of these areas are characterized by (1) bleeding into an enclosed space, (2) compression of vital tissue, and (3) potential loss of life, limb, or function. Since bleeding episodes also cause anxiety and fear in patients and families, the nursing interventions of communication, reassurance, education, and support will help them through these crises.
TREATMENT REGIMENS IN HEMOPHILIA
Hemophilia is managed by either on-demand therapy or prophylaxis. In on-demand therapy, factor concentrate infusion therapy is initiated at the onset of a bleeding episode. In prophylaxis therapy, factor concentrate is infused on a regular basis to prevent bleeding episodes from occurring. Prophylaxis is now the mainstay of treatment regimen for children with severe hemophilia.
With the introduction of safe recombinant factor concentrates in the mid-1990's, children with severe hemophilia were increasingly placed on prophylactic regimens. These same children are now adults, and many choose to stay on prophylaxis if the resources are available to them. Many older adults are also opting for a routine prophylaxis regimen to decrease bleeding episodes, even though they may have joint damage from years of hemophilia-related bleeding (See Chapter 6).
Individuals with hemophilia treated with factor concentrates prior to 1985 may be infected with HIV and/or hepatitis B or C. These infections and the various therapeutic agents used in their treatment may contribute to the severity of bleeding episodes (e.g., individuals taking protease inhibitor drugs may experience an increase in bleeding episodes or prolonged bleeding). Medications used to control chronic pain from arthritic joints also need to be considered in assessing and treating acute bleeds (e.g., individuals taking non-steroidal anti-inflammatory drugs may experience prolonged bleeding episodes).
FUNDAMENTAL PRINCIPLES OF CARE FOR ANY LIFE-OR LIMB-THREATENING BLEED
1.
Obtain history of the event.
2.
Obtain history of hemophilia including type, severity, inhibitor status, last factor replacement time and dose, current medications, and associated medical history (e.g., HIV, hepatitis B or C infection).
Inhibitor patients who use prothrombin complex concentrates (PCC) or activated prothrombin complex concentrates (aPCC) and have had a recent infusion (within three to four hours) should have careful consideration in the determination of their factor replacement needs. Prothrombin complex and activated prothrombin complex concentrates contain factors II, VII, IX, and X. The half-life of each factor differs, ranging from 2 hours for factor VII to 72 hours for factor II. Frequent and repeated doses of these concentrates allow accumulation of the longer-lived factors, predisposing the patient to a thromboembolic state. Disseminated intravascular coagulation and intramural cardiac thrombus have been reported as a result of too frequent or too rapid administration of these concentrates. (17) Thombotic events may also be precipitated with the concurrent use of PCC or APCC's and recombinant factor VIIa. Concurrent systemic use of Amicar, which inhibits fibrinolysis, may also predispose the patient to thrombus formation. (23) 
CENTRAL NERVOUS SYSTEM BLEEDS
Intracranial or spinal cord bleeding can occur spontaneously or as the result of trauma in individuals with bleeding disorders. Intracranial hemorrhage remains a leading cause of death among patients with hemophilia. Such hemorrhages can occur in newborns, children, and adults of all ages. Common bleeding sites are subdural, epidural, subarachnoid, intra-ventricular, and intra-cerebral spaces. Brainstem or multiple site bleeds are less frequent. Patients with central nervous system bleeds do not always show external symptoms, making these cases potentially difficult to evaluate. When signs such as a scalp laceration or hematoma are present, the patient should be treated immediately with a major dose (100% dose) of factor replacement therapy, undergo a CT scan of the head, and be evaluated and observed in the hospital (4). The provider should not rely solely on bruises or signs and symptoms of central nervous system (CNS) bleeding, which may only develop hours or even days after the initial trauma. The trauma history should trigger the initial treatment.
Intraspinal hemorrhage is less frequent than intracranial bleeding. One review showed trauma as a causative factor in only one third of the cases; 75% of hematomas were extramedullary, and 25% were intramedullary. (4) A history of trauma followed by progressive pain and neurologic changes, such as parasthesia or numbness in a limb or motor weakness, leads to a diagnosis of intraspinal hemorrhage. Symptoms of acute neck or back pain or trauma should also suggest this diagnosis. Treatment with factor concentrate should begin immediately, with neurological consultation and follow-up care. Prompt treatment will prevent paralysis and neurological sequelae as well as an extensive rehabilitation period. Factor administration should occur as soon as the diagnosis is suspected, before a diagnostic workup and prior to any invasive procedure, such as lumbar puncture. Any traumatic injury which could potentially precipitate an intraspinal hemorrhage should be treated with a major dose of factor, even if the patient is not symptomatic.
EVALUATION AND TREATMENT
Hemophilia patients presenting with a history of significant head trauma or sustained headache greater than four hours (3, 22) should receive an immediate infusion of factor concentrate to raise the factor level to at least 100% (i.e., 50-60 IU/kg FVIII concentrate or 100-110 IU/kg FIX concentrate). A complete neurological evaluation should be performed as a baseline and be followed with regular reassessment and monitoring for signs of increased intracranial pressure.
Laboratory evaluation:
If stat labs are available, blood should be drawn for CBC and platelet count. If the patient has known or suspected liver disease, a prothrombin time (PT) should be ordered. If the timing and the amount of the patient's last infusion is known, a factor level assay may be useful in providing infused factor recovery information. A factor inhibitor screen will provide baseline inhibitor information, especially if the patient faces large and prolonged exposure to factor concentrate. These samples should be obtained prior to administering factor concentrate. However, these results will not be immediately available; treatment should not be delayed waiting for these results.
Treatment: Administration of factor concentrate should not be delayed or postponed in order to obtain lab work when there is potential brain hemorrhage. CT scans or MRI should be obtained. Airway maintenance, IV access, drug therapy, and cervical stabilization (if indicated by diagnosis) should be initiated for patients presenting with any neurological deficit. Factor replacement to 100% should always be given as the first intervention; it should be given empirically, prior to obtaining lab testing or diagnostic imaging. 
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PATIENT AND FAMILY EDUCATION
Patients and families must be made aware of the potential outcomes and sequelae of any intracranial or CNS bleed. Head injuries can be difficult to evaluate, especially if no symptoms are present. Any suspected bleed, whether it be a witnessed or a reported incident of trauma and whether or not symptoms are present, should always be treated with factor concentrate first, followed by diagnostic tests. Headache should never be medicated with aspirin or NSAIDS as they inhibit platelet function.
Every person with hemophilia and members of their family should be well versed in the signs and symptoms of CNS bleeding. This information should be given to parents when a child is newly diagnosed with hemophilia, and bleeding disorders care providers should provide additional education on an ongoing basis. Stressing prevention, such as the use of bike helmets, care seats, and seat belts; recognition of symptoms; and immediate medical intervention provide parents with an action plan of care. Reassurance to the family is essential, as intracranial/CNS bleeding is a very frightening event. Patients and families should be taught to assume that any head injury is life-threatening and to treat such a bleeding episode immediately, raising the patient's factor level to 100% prior to going to an emergency department if possible or else immediately on admission to an emergency department. Hemophilia nurses and hemophilia treatment centers are best able to assess and provide for the patient's and family's level of understanding and educational needs.
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PHARYNGEAL BLEEDS
The pharynx is divided into three parts: the nasopharynx (nose and soft palate), the oropharynx (the back of the mouth and upper throat), and the laryngopharynx (epiglottis to the larynx). This is a densely vascular area, from the mouth to the great vessels and muscles in the neck. Bleeding can occur in any of these areas.
NASOPHARYNGEAL BLEEDS
Nasopharyngeal bleeds, usually epistaxis, pose little threat unless the patient loses large volumes of blood. A small child may experience significant blood loss over the course of several days. Swallowing blood from a slow but unrelenting site of bleeding in the nose may produce severe anemia to the point where the child may be in need of a transfusion of packed red blood cells or whole blood. Because the child may be swallowing the blood, the parent may not be aware of the large cumulative amount of blood loss. Pallor, listlessness, tachycardia, and clammy skin should initiate an evaluation for anemia. Any report by a parent of frequent nose bleeding or uncontrolled nose bleeding should initiate an evaluation.
Treatment: Pressure on the nose for 15 minutes while in a sitting position, with head slightly forward, will usually stop the bleeding as well as prevent aspiration or swallowing of blood that can lead to nausea and vomiting. Nasal packing or topical agents may be used if necessary. Cauterization and factor infusion may also be indicated to control bleeding. Adjunctive treatment with aminocaproic acid (Amicar) or transexamic acid may be useful. Amicar inhibits fibrinolysis, so the clot is maintained to tamponade the bleeding site. Dosing regimen for Amicar elixir is 100mg/ kg up to a maximum dose of 3-4g every 6 hours for 5-7 days for mild bleeds or 10-14 days for more severe or prolonged bleeds. For pediatric patients the recommended oral dose is 50-100mg/kg (not to exceed 4 gms) every 6 hours for 5-7 days or up to 10-14 days following dental extraction. (6) For oral bleeds and extractions it is recommended to swish the Amicar before swallowing it because Amicar elixir also has a topical effect as well as an internal effect. Duration of therapy varies with the bleeding episode (21).
MOUTH, OROPHARYNGEAL, AND RETROPHARYNGEAL BLEEDS
These can lead to acute respiratory emergencies. Bleeding episodes may be spontaneous or induced by surgery, infection, or trauma. Mouth bleeds from small cuts, gums, or tooth loss usually are not a problem unless the bleeding continues to the point of volume depletion. General measures, such as avoiding straws and hot fluids and using cold, moist household air, as well as adjunctive therapy with Amicar in conjunction with factor concentrates provide good hemostasis. Bleeding at the base of the tongue, bleeding into a dissecting tract caused by dental infection or anesthetic injection, and bleeding from a lacerated cheek or tongue may cause pooling of blood in the oropharynx, potentially obstructing the airway (1).
Retropharyngeal bleeding may occur following an infection such as pharyngitis or peritonsillar abscess or may result from a hematoma secondary to throat trauma. Airway patency is of major concern, as these conditions can easily lead to obstruction.
Evaluation: Patients should be assessed for ability to swallow saliva and receive a lateral neck x-ray to check for the presence of a mass. 1. Obtain IV access and blood for lab studies 2. Infuse with factor concentrate to raise factor levels to 100%. Patients and families must be aware of the hazardous nature of pharyngeal bleeds and the need for immediate factor therapy. Signs and symptoms must be clearly presented and reinforced. Specific educational needs include: 1. Why bleeds in this area are problematic.
2.
Observe for symptoms, such as difficulty breathing, neck swelling, inability to swallow, change in voice, choking, discoloration. 3.
Identify causes of bleeds such as infection or trauma, severe coughing, or vomiting.
4.
Immediately raise factor level to 100%. 5.
Seek professional care if any symptoms occur. 6.
Never medicate pain with aspirin, ibuprofen or other NSAID products.
ABDOMINAL BLEEDS
Acute abdominal pain in a patient with hemophilia may have many origins, such as GI tract bleeding, hematomas (spontaneous or trauma induced), pseudotumors, iliopsoas bleed, or retroperitoneal bleeding. Because of its size, the peritoneal cavity can hold significant amounts of blood with little external evidence of the sequestered blood volume. Any abdominal pain that is associated with hip or groin pain or is accompanied by inability to bear weight on a leg or inability to lie flat may indicate an iliopsoas bleed. While this area is not part of the abdomen per se, large amounts of blood can accumulate in this muscle group in the retroperitoneal space, causing intense pain and significant blood loss.
SYMPTOMS, LABORATORY EVALUATION, TREATMENT
The primary presenting symptom of an abdominal bleed is usually pain, although bleeding into the gastrointestinal tract may not produce pain. Patients may also complain of dizziness, light headedness, shortness of breath, nausea, vomiting, or rectal bleeding. Clinical evidence of volume sequestration in the peritoneal cavity include tachycardia, increased respiratory rate, orthostatic blood pressure changes, referred pain to the shoulder or scapula, lowered blood pressure, pallor, clammy skin, hematemesis, or rectal bleeding.
Laboratory values include decreased hemoglobin and hematocrit levels, altered oxygen levels, changes in white count if infection or inflammation is present, and altered values for organspecific tests, such as increased amylase in pancreatitis.
Treatment:
Treat empirically with factor concentrate to 100% as a first intervention. Do not wait for lab results and do not perform procedures before factor is given. Retroperitoneal bleeding may present as flank pain and may not be trauma-induced. Hematuria and fever may or may not be present. Severe, continued flank pain needs medical evaluation. Aspirin and ibuprofen products for pain control should always be avoided, as should PeptoBismol liquid or tablets, which contain aspirin, due to their platelet effect. Trauma to the abdomen may be difficult to evaluate. A child who receives a blow to the abdomen, especially one that is hard enough to cause bruising or crying in the child, should receive factor replacement. Do not wait for signs or symptoms of bleeding, treat first.
Nursing Assessment
COMPARTMENT SYNDROMES
The second most common type of hemorrhage in hemophilia is muscle hemorrhage. Common sites of muscle hemorrhage are iliopsoas, quadriceps, and gastrocnemius muscles and the common muscles of the flexor surface of the forearm. Bleeding may be precipitated by trauma or fractures or may be spontaneous. Compartment syndrome is an increase in the pressure within a muscle sheath following musculoskeletal trauma. It can occur up to 6 days post-trauma, but usually occurs between 12 hours and three days after the trauma. The increased pressure can compress blood vessels and compromise circulation in the already injured extremity. (15) Bleeding into the large muscle compartments of the upper and lower arms, thigh, and calf can cause tissue compression and lead to nerve compression, tissue death, and loss of function or the limb for a person with hemophilia. Amounts of blood loss are often underestimated but are reported to be 1 to 2 liters in the upper arm muscle, 0.5 to 1 liter in the forearm, 1to 2 liters in the thigh, and 0.5 to 1.5 liters in the calf.
SYMPTOMS AND TREATMENT
Early symptoms of muscle hemorrhage include tingling and warmth, followed by increasing pain, swelling, and muscle spasm. Late signs include pallor, paresthesia, and decreased capillary refill. Pulselessness of an extremity occurs as a very late sign.
Treatment: Treatment for muscle hemorrhage consists of factor replacement, immobilization, ice, elevation, and analgesia. Severe case of muscle hemorrhage and compartment syndrome may require surgical decompression by fasciotomy. The hematologist should always be consulted before fasciotomy is performed. This procedure can often be avoided with aggressive factor therapy. Hemophilia patients who receive fasciotomy will need to be treated as other surgical cases and receive prolonged post-surgery factor management. Always treat with factor as the first intervention and prior to any invasive procedures, including pressure monitoring.
Complications of muscle hemorrhage can range from stiffness, muscle atrophy, decreased flexibility, destruction of the muscle fiber with replacement by non-elastic fibrous tissue, joint contractures, and in extreme cases limb loss.
Nursing Care of Compartment Syndrome
I.
Primary Assessment
